摘要
微粒是直径0.1~1.0μm的囊泡样结构。它是细胞在活化或凋亡后产生的。循环微粒的水平在多种心血管疾病中是升高的。它在血浆中的升高被认为是血管功能改变的一个生物学标志。本篇综述旨在总结和提供循环微粒在急性冠脉综合征血栓形成机制中扮演的角色的最新研究进展。
Circulating microparticles(cMPs) are vesicle-like structures with a diameter of 0.1-1.0 μm, which are produced by cells after activation or apoptosis. The levels of circulating microparticles are elevated in many cardiovascular diseases. Its elevation in plasma is considered a biological marker of altered vascular function. This review aims to summarize and provide the latest research progress on the role of circulating microparticles in the mechanism of acute coronary syndrome thrombosis.
作者
祖丽批亚·艾力(综述)
穆叶赛·尼加提(审校)
ZULIPIYA Aili;MUYESAI Nijiati(Xinjiang Medical University,Urumqi 830001,Xinjiang,CHINA;Department of Emergency,Xinjiang Uighur Autonomous Region People's Hospital,Urumqi 830001,Xinjiang,CHINA)
出处
《海南医学》
CAS
2020年第7期906-909,共4页
Hainan Medical Journal
基金
国家自然科学基金(编号:81760068)。
关键词
急性冠脉综合征
微粒
血栓形成
预测作用
进展
Acute coronary syndrome
Microparticles
Thrombosis
Prediction effect
Prognosis
